Skip to Content Facebook Feature Image

Sky Labs Launches 'CART ON', the World's First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards

Business

Sky Labs Launches 'CART ON', the World's First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards
Business

Business

Sky Labs Launches 'CART ON', the World's First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards

2026-02-10 13:26 Last Updated At:13:45

- Establishment of a blood pressure monitoring lineup that addresses every environment, from daily life to hospital wards

SEOUL, South Korea, Feb. 10, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 10th that it has launched 'CART ON', the world's first ward-specific blood pressure monitoring solution that utilizes a ring-type blood pressure monitor to automatically measure and manage the blood pressure data of inpatients.

With the launch of CART ON, Sky Labs' business scope has expanded beyond the existing outpatient and consumer markets into the field of inpatient ward monitoring. As the ward-specific solution is added to the certified medical devices-the 'CART BP pro' for outpatient clinical use and the 'CART BP' for general consumers-a lineup has been completed that addresses every stage where blood pressure measurement is required, from daily life to hospital wards.

The CART ON solution is optimized for enhancing convenience in medical settings by streamlining cumbersome measurement procedures. When medical staff prescribe a ring-type monitor instead of a conventional cuff-type device for patients who require 24-hour Ambulatory Blood Pressure Monitoring (ABPM), the device's built-in photoplethysmography (PPG) sensor automatically measures the patient's blood pressure and collects relevant data.

The collected data is linked with Seers Technology's inpatient monitoring platform, 'thynC', and is automatically transmitted to and recorded in the nurse station dashboard and the hospital's Electronic Medical Record (EMR) system. Currently, Daewoong Pharmaceutical, a South Korean pharmaceutical company, holds the exclusive domestic sales rights for this solution and plans to supply it to hospital distribution networks nationwide.

Sky Labs has secured global-level technical and clinical reliability by conducting comparative clinical trials with existing standard methodsn — including Auscultation, cuff-based 24-hour Ambulatory Blood Pressure Monitoring (ABPM), and Invasive Arterial Line (A-line) — to prove the clinical validity of the ring-type blood pressure monitor applied to CART ON. Notably, through comparative trials with the A-line, considered the 'Gold-Standard' of blood pressure measurement, the company proved that precise monitoring is possible even in situations with high blood pressure fluctuations.

The introduction of the solution is expected to further enhance the work efficiency of medical staff in wards. In terms of nursing, it reduces potential errors that may occur during manual entry and simplifies recording and reporting tasks, helping nurses focus on their core professional duties such as medication and fluid management. Doctors can also improve the accuracy of diagnosis and the appropriateness of drug prescriptions based on objective data measured periodically.

The physical discomfort experienced by patients is also expected to improve. Since there is no pressure from tightening the arm or mechanical noise, the sleep disturbance issues caused by conventional cuff-type blood pressure monitors can be minimized. In addition, measurement is possible without any separate restrictions even when the patient is moving or active within the hospital, allowing for the easy collection of 24-hour blood pressure fluctuation data.

Jack Byunghwan Lee, CEO of Sky Labs, stated, "CART ON is a solution that improves the efficiency of managing hypertensive patients in wards through clinically proven technology." He added, "We will continue to advance vital signal monitoring technologies, including blood pressure, to contribute to the establishment of a smart ward environment that simultaneously enhances work efficiency for medical staff and convenience for patients."

About Sky Labs https://skylabs.io/en/

Founded in September 2015, Sky Labs is a healthcare company that develops and operates "CART", a ring-type medical device and platform for monitoring chronic disease patients. Since the first CART was developed in 2020 for atrial fibrillation monitoring using cardiac signals from optical sensors, the company has expanded its capabilities. In 2023, Sky Labs received medical device approval for "CART BP pro," a ring-type monitor designed for 24-hour blood pressure measurement. In 2024, CART BP pro was recognized by the Health Insurance Review and Assessment Service (HIRA) under the existing medical procedure of '24-hour ambulatory blood pressure monitoring' (reimbursement code 'E6547'), and is currently being prescribed in hospitals and clinics across Korea. Furthermore, in September 2025, the company launched "CART BP," a consumer-grade ring-type blood pressure monitor, which is available through its official online store and various other online channels.

Media Inquiries

Inok Jung inok.jung@skylabs.io
Bomi Lee bomi.lee@skylabs.io

 

- Establishment of a blood pressure monitoring lineup that addresses every environment, from daily life to hospital wards

SEOUL, South Korea, Feb. 10, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 10th that it has launched 'CART ON', the world's first ward-specific blood pressure monitoring solution that utilizes a ring-type blood pressure monitor to automatically measure and manage the blood pressure data of inpatients.

With the launch of CART ON, Sky Labs' business scope has expanded beyond the existing outpatient and consumer markets into the field of inpatient ward monitoring. As the ward-specific solution is added to the certified medical devices-the 'CART BP pro' for outpatient clinical use and the 'CART BP' for general consumers-a lineup has been completed that addresses every stage where blood pressure measurement is required, from daily life to hospital wards.

The CART ON solution is optimized for enhancing convenience in medical settings by streamlining cumbersome measurement procedures. When medical staff prescribe a ring-type monitor instead of a conventional cuff-type device for patients who require 24-hour Ambulatory Blood Pressure Monitoring (ABPM), the device's built-in photoplethysmography (PPG) sensor automatically measures the patient's blood pressure and collects relevant data.

The collected data is linked with Seers Technology's inpatient monitoring platform, 'thynC', and is automatically transmitted to and recorded in the nurse station dashboard and the hospital's Electronic Medical Record (EMR) system. Currently, Daewoong Pharmaceutical, a South Korean pharmaceutical company, holds the exclusive domestic sales rights for this solution and plans to supply it to hospital distribution networks nationwide.

Sky Labs has secured global-level technical and clinical reliability by conducting comparative clinical trials with existing standard methodsn — including Auscultation, cuff-based 24-hour Ambulatory Blood Pressure Monitoring (ABPM), and Invasive Arterial Line (A-line) — to prove the clinical validity of the ring-type blood pressure monitor applied to CART ON. Notably, through comparative trials with the A-line, considered the 'Gold-Standard' of blood pressure measurement, the company proved that precise monitoring is possible even in situations with high blood pressure fluctuations.

The introduction of the solution is expected to further enhance the work efficiency of medical staff in wards. In terms of nursing, it reduces potential errors that may occur during manual entry and simplifies recording and reporting tasks, helping nurses focus on their core professional duties such as medication and fluid management. Doctors can also improve the accuracy of diagnosis and the appropriateness of drug prescriptions based on objective data measured periodically.

The physical discomfort experienced by patients is also expected to improve. Since there is no pressure from tightening the arm or mechanical noise, the sleep disturbance issues caused by conventional cuff-type blood pressure monitors can be minimized. In addition, measurement is possible without any separate restrictions even when the patient is moving or active within the hospital, allowing for the easy collection of 24-hour blood pressure fluctuation data.

Jack Byunghwan Lee, CEO of Sky Labs, stated, "CART ON is a solution that improves the efficiency of managing hypertensive patients in wards through clinically proven technology." He added, "We will continue to advance vital signal monitoring technologies, including blood pressure, to contribute to the establishment of a smart ward environment that simultaneously enhances work efficiency for medical staff and convenience for patients."

About Sky Labs https://skylabs.io/en/

Founded in September 2015, Sky Labs is a healthcare company that develops and operates "CART", a ring-type medical device and platform for monitoring chronic disease patients. Since the first CART was developed in 2020 for atrial fibrillation monitoring using cardiac signals from optical sensors, the company has expanded its capabilities. In 2023, Sky Labs received medical device approval for "CART BP pro," a ring-type monitor designed for 24-hour blood pressure measurement. In 2024, CART BP pro was recognized by the Health Insurance Review and Assessment Service (HIRA) under the existing medical procedure of '24-hour ambulatory blood pressure monitoring' (reimbursement code 'E6547'), and is currently being prescribed in hospitals and clinics across Korea. Furthermore, in September 2025, the company launched "CART BP," a consumer-grade ring-type blood pressure monitor, which is available through its official online store and various other online channels.

Media Inquiries

Inok Jung inok.jung@skylabs.io
Bomi Lee bomi.lee@skylabs.io

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Sky Labs Launches 'CART ON', the World's First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards

Sky Labs Launches 'CART ON', the World's First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards

  • Empowering ASEAN & global businesses to make sound data-driven decisions while ensuring privacy and compliance
  • KUALA LUMPUR, Malaysia, Feb. 10, 2026 /PRNewswire/ -- Athenatech AI Sdn Berhad (athenatech.ai ), one of Malaysia's top six AI start-ups to watch, today announced the launch of subsidiary AxxonAI (axxonai.com), a Large Language Model (LLM) based synthetic data intelligence platform. This milestone positions AxxonAI as the first Malaysian company to offer this capability, addressing the growing challenges of data scarcity and privacy constraints faced by enterprises across the ASEAN region and global markets.

    SUPPORTING MALAYSIA'S NATIONAL AI AGENDA

    In line with Malaysia's aspiration to become an AI Nation by 2030, guided by the National AI Action Plan 2026–2030, Athenatech.ai and AxxonAI are aligning their innovation efforts with national priorities set out by the National AI Office (NAIO). This alignment reflects a shared commitment to advancing next-generation AI capabilities that drive productivity, innovation, and sustainable economic growth.

    As part of this initiative, AxxonAI is establishing a Global Delivery Centre (GDC) focused on AI training, synthetic data, and generative AI insights. The GDC aims to deliver measurable impact across key sectors while supporting Malaysia's ambition to strengthen its AI ecosystem and progressively position the country as a trusted and competitive AI hub within ASEAN.

    AxxonAI has also been granted Malaysia Digital status, reinforcing the company's commitment to supporting Malaysia's growth as a regional AI hub serving global markets.

    AXXONAI: A UNIQUE PLATFORM

    Designed to emulate real-world data patterns with astonishing accuracy, this technology enables organisations across industries to build impactful, effective, and ethical AI-driven solutions that support growth, innovation, and better decision-making. AxxonAI is a privacy-centred generative AI with a multi-tiered synthetic data cognitive intelligence platform, designed for enterprise-level artificial intelligence applications in the ASEAN region and beyond.

    AxxonAI generates synthetic data using Generative Adversarial Networks (GANs), Retrieval-Augmented Generation (RAG) with LLMs. This enables the creation of privacy-safe, statistically equivalent datasets for industries working with real-world data. Rather than deploying one-size-fits-all datasets, AxxonAI can now create datasets tailored to the local market, recognising its unique data patterns, regulatory requirements, and business objectives.

    The platform's added feature is data decoupling and fine-tuning, which are important concepts in machine learning and data engineering.  It separates or isolates different aspects of synthetic data generation to improve control, quality, and utility.  Fine-tuning involves adapting pre-trained models using artificially generated datasets. This becomes a significant advancement for Segmentation & Hyper-personalisation in BANI (Brittle, Anxious, Nonlinear, Incomprehensible) consumer contexts.

    Sonny (Soumitra) Dey, the Founder & Chief Executive Officer of Athenatech.ai and AxxonAI, emphasised, "AI should be both powerful and principled. Our synthetic data engine, AxxonAI, proves that businesses don't have to choose between innovation and privacy. This technology empowers enterprises to achieve real growth while maintaining high standards of data ethics and security. AxxonAI is specifically built to meet the needs of businesses in Asia and the ASEAN region. Its localisation and personalised synthetic data platform, with a focus on ASEAN, distinguish us in the market. We aim to enable our partners to make optimal business decisions, supported by reliable, real-world data. In the coming months, we will be partnering with numerous companies on different versions of our AxxonAI integrated with Agentic Function."

    LOCAL FOCUS, GLOBAL REACH

    Currently, ASEAN enterprises and companies lack sufficient localised and regional data[1] that is both readily available and structured in formats suitable for effectively training AI models for the regional market. Existing AI data solutions lack regional customisations and are cost-prohibitive for businesses, particularly for SMEs to adopt fully.  While general models are available, the datasets are global-centric and not tailored to the regional market.  

    The cost of using global datasets is also higher[2], as they include all available data and are not personalised and localised for the region's requirements. Consequently, the outputs provided to customers may not be as accurate or aligned with local insights. Furthermore, strict privacy regulations under the Personal Data Protection Act 2010/ General Data Protection Regulation (PDPA/GDPR) limit companies' ability to use real-world customer data for AI training and development.

    AxxonAI is designed to help unlock a business's full potential while ensuring data privacy and reducing compliance risk. What makes AxxonAI stand out is its ASEAN focus and the use of a localised LLM designed for regional languages and business practices, supported by the Quality Score feature included in the platform. AxxonAI is also designed with PDPA compliance at its core and, importantly, is affordable for even SMEs to adopt for their own use.

    PARTNERSHIP IN HEALTHCARE

    AxxonAI, in partnership with Sancy Berhad, one of Malaysia's leading digital healthcare solution providers, will now enable clinicians and administrators to derive powerful, actionable insights from patient data while maintaining absolute compliance with privacy regulations and eliminating the risk of personal identification. The collaboration marks a significant step toward transforming healthcare delivery through secure, intelligent, and sovereign AI-driven solutions.                                                                             

    Under this partnership, AxxonAI's advanced synthetic data generation and intelligence capabilities will integrate with Sancy Berhad's healthcare ecosystem to accelerate innovation in patient care, operational efficiency, and healthcare tourism. The collaboration will initially focus on two flagship initiatives:

    • Connected Care: A data-driven healthcare tourism solution designed to attract international patients while ensuring privacy and compliance with local regulations.
    • Ring: A patient-centric care model that leverages synthetic data and predictive intelligence to improve outcomes, reduce costs, and streamline hospital-to-home care journeys.

    KUALA LUMPUR, Malaysia, Feb. 10, 2026 /PRNewswire/ -- Athenatech AI Sdn Berhad (athenatech.ai ), one of Malaysia's top six AI start-ups to watch, today announced the launch of subsidiary AxxonAI (axxonai.com), a Large Language Model (LLM) based synthetic data intelligence platform. This milestone positions AxxonAI as the first Malaysian company to offer this capability, addressing the growing challenges of data scarcity and privacy constraints faced by enterprises across the ASEAN region and global markets.

    SUPPORTING MALAYSIA'S NATIONAL AI AGENDA

    In line with Malaysia's aspiration to become an AI Nation by 2030, guided by the National AI Action Plan 2026–2030, Athenatech.ai and AxxonAI are aligning their innovation efforts with national priorities set out by the National AI Office (NAIO). This alignment reflects a shared commitment to advancing next-generation AI capabilities that drive productivity, innovation, and sustainable economic growth.

    As part of this initiative, AxxonAI is establishing a Global Delivery Centre (GDC) focused on AI training, synthetic data, and generative AI insights. The GDC aims to deliver measurable impact across key sectors while supporting Malaysia's ambition to strengthen its AI ecosystem and progressively position the country as a trusted and competitive AI hub within ASEAN.

    AxxonAI has also been granted Malaysia Digital status, reinforcing the company's commitment to supporting Malaysia's growth as a regional AI hub serving global markets.

    AXXONAI: A UNIQUE PLATFORM

    Designed to emulate real-world data patterns with astonishing accuracy, this technology enables organisations across industries to build impactful, effective, and ethical AI-driven solutions that support growth, innovation, and better decision-making. AxxonAI is a privacy-centred generative AI with a multi-tiered synthetic data cognitive intelligence platform, designed for enterprise-level artificial intelligence applications in the ASEAN region and beyond.

    AxxonAI generates synthetic data using Generative Adversarial Networks (GANs), Retrieval-Augmented Generation (RAG) with LLMs. This enables the creation of privacy-safe, statistically equivalent datasets for industries working with real-world data. Rather than deploying one-size-fits-all datasets, AxxonAI can now create datasets tailored to the local market, recognising its unique data patterns, regulatory requirements, and business objectives.

    The platform's added feature is data decoupling and fine-tuning, which are important concepts in machine learning and data engineering.  It separates or isolates different aspects of synthetic data generation to improve control, quality, and utility.  Fine-tuning involves adapting pre-trained models using artificially generated datasets. This becomes a significant advancement for Segmentation & Hyper-personalisation in BANI (Brittle, Anxious, Nonlinear, Incomprehensible) consumer contexts.

    Sonny (Soumitra) Dey, the Founder & Chief Executive Officer of Athenatech.ai and AxxonAI, emphasised, "AI should be both powerful and principled. Our synthetic data engine, AxxonAI, proves that businesses don't have to choose between innovation and privacy. This technology empowers enterprises to achieve real growth while maintaining high standards of data ethics and security. AxxonAI is specifically built to meet the needs of businesses in Asia and the ASEAN region. Its localisation and personalised synthetic data platform, with a focus on ASEAN, distinguish us in the market. We aim to enable our partners to make optimal business decisions, supported by reliable, real-world data. In the coming months, we will be partnering with numerous companies on different versions of our AxxonAI integrated with Agentic Function."

    LOCAL FOCUS, GLOBAL REACH

    Currently, ASEAN enterprises and companies lack sufficient localised and regional data[1] that is both readily available and structured in formats suitable for effectively training AI models for the regional market. Existing AI data solutions lack regional customisations and are cost-prohibitive for businesses, particularly for SMEs to adopt fully.  While general models are available, the datasets are global-centric and not tailored to the regional market.  

    The cost of using global datasets is also higher[2], as they include all available data and are not personalised and localised for the region's requirements. Consequently, the outputs provided to customers may not be as accurate or aligned with local insights. Furthermore, strict privacy regulations under the Personal Data Protection Act 2010/ General Data Protection Regulation (PDPA/GDPR) limit companies' ability to use real-world customer data for AI training and development.

    AxxonAI is designed to help unlock a business's full potential while ensuring data privacy and reducing compliance risk. What makes AxxonAI stand out is its ASEAN focus and the use of a localised LLM designed for regional languages and business practices, supported by the Quality Score feature included in the platform. AxxonAI is also designed with PDPA compliance at its core and, importantly, is affordable for even SMEs to adopt for their own use.

    PARTNERSHIP IN HEALTHCARE

    AxxonAI, in partnership with Sancy Berhad, one of Malaysia's leading digital healthcare solution providers, will now enable clinicians and administrators to derive powerful, actionable insights from patient data while maintaining absolute compliance with privacy regulations and eliminating the risk of personal identification. The collaboration marks a significant step toward transforming healthcare delivery through secure, intelligent, and sovereign AI-driven solutions.                                                                             

    Under this partnership, AxxonAI's advanced synthetic data generation and intelligence capabilities will integrate with Sancy Berhad's healthcare ecosystem to accelerate innovation in patient care, operational efficiency, and healthcare tourism. The collaboration will initially focus on two flagship initiatives:

    Both initiatives pave the way for a more cost-efficient, patient-centric, and effective healthcare system.

    Prabuddha Chakravertty, Group Managing Director of Sancy Berhad, shared, "Through AxxonAI's advanced synthetic data intelligence platform, Sancy Berhad is transforming how it approaches patient care, resource allocation, and clinical decision-making. The platform generates statistically accurate, regulatory-compliant synthetic patient profiles that mirror real-world populations, empowering healthcare teams to optimise treatment pathways, predict critical care demands, and improve patient outcomes without ever compromising individual privacy."

    COMING UP

    Multiple versions of AxxonAI are currently under development, including implementations based on Small Language Models (SLMs) and integrations with Agentic Functions, specifically designed for SMEs in Malaysia. The team is testing and refining these domain-specific AI models to launch solutions for Agriculture, Automotive, BFSI, Telecommunications, Property, Logistics, Supply Chain, and Media & Entertainment by early 2026.

    Sonny (Soumitra) Dey (ex-Accenture) currently leads a core team at AxxonAI, comprising top Malaysian and Global AI experts. The able team is mentored by Malaysian industry stalwarts such as Sharani Mohamed (Technopreneur, known for Government Defence & Security Technology Solutions Architect) and Omar Shaari (Ex-Dentsu).

    The core team of AxxonAI, consists of: Sutapa Bhattacharya, Managing Partner, Strategy, Innovation & Business Continuity (Ex-Leo Burnett and TNB), Sudip Ghosh, CRO – BFIS/Telco/Energy (Former JAPAC & MEA Sales, Oracle & IBM), Teruchelwam Pillai, Chief Technology Officer - Healthcare (Ex-Sime Darby), Dr S. Katae, Chief AI Engineer - LLM (Ex-Deep Mind), Gloria Gomes, Strategy & Insight (Ex-Byte Dance Malaysia), Gerald Faust, Sovereign Cloud & Data Centres  (Ex JAPAC & ME Lead SNP & SAP), Amit Kurhekar, Martech (Ex Moneylion and P&G), Jacek Kucieba, Chief of Business Efficiency and Impact (Ex SAS), Ragunathan Marthammuthu, AI Academy & L&D (Right Track Education), Haris Mateen, Chief of Agentic Solutions (Ex MIMS), Saravanan Ramaiah, Chief Finance Officer (Ex-IPG), Sugato Banerjee, Country Head, South Asia and Dubai (Ex-JWT, Standard Chartered, Visa, Videocon),  and Adriel Chan, Lead - GTM

    ## END ##

    About AxxonAI 

    AxxonAI, developed by Athenatech.ai, a Malaysia Digital–certified company, is a next-generation synthetic GenAI platform that empowers organisations to maximise the value of their data—without compromising privacy, security, or regulatory compliance.

    Built on advanced LLM frameworks and methodologies, AxxonAI produces high-fidelity synthetic data that mirrors real-world statistical patterns while containing zero personally identifiable information. This enables enterprises to innovate, analyse, and scale with confidence.

    AxxonAI's core capability lies in data decoupling and fine-tuning, key concepts in machine learning and data engineering. These processes separate and control aspects of synthetic data generation, improving data quality, flexibility, and practical usefulness. Fine-tuning involves customising pre-trained models using artificially generated datasets, delivering significant advantages for segmentation and hyper-personalisation in BANI consumer environments.

    The BANI (Brittle, Anxious, Nonlinear, Incomprehensible) world presents distinct challenges for understanding consumers. In such volatile conditions, consumer behaviour shifts rapidly and unpredictably. Traditional datasets quickly become outdated, while privacy regulations restrict access to detailed personal information. Synthetic data helps model uncertainty and volatility, enabling the creation of scenarios that reflect the fragile, nonlinear dynamics of real-world consumer decision-making. This is where AxxonAI shines.

    [1] ASEAN RESPONSIBLE AI ROADMAP (2025 – 2030): https://asean.org/wp-content/uploads/2025/02/ASEAN-Responsible-AI-Roadmap-Final.docx.pdf

    [2] How Much Does It Cost to Train an AI Model?: https://www.talentelgia.com/blog/how-much-does-it-cost-to-train-an-ai-model/ 

    [1] ASEAN RESPONSIBLE AI ROADMAP (2025 – 2030): https://asean.org/wp-content/uploads/2025/02/ASEAN-Responsible-AI-Roadmap-Final.docx.pdf

    [2] How Much Does It Cost to Train an AI Model?: https://www.talentelgia.com/blog/how-much-does-it-cost-to-train-an-ai-model/ 

     

    ** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

    Malaysia's First Large Language Model based Synthetic Data Intelligence Platform with Agentic function, AxxonAI launched with healthcare partner Sancy Berhad

    Malaysia's First Large Language Model based Synthetic Data Intelligence Platform with Agentic function, AxxonAI launched with healthcare partner Sancy Berhad

Recommended Articles